www.fdanews.com/articles/85920-forest-labs-spain-s-almirall-in-drug-development-pact
FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT
April 10, 2006
Forest Laboratories Inc. and closely held, Barcelona-based pharmaceutical company Almirall agreed to develop, market and distribute the Spanish company's chronic obstructive pulmonary disease treatment, LAS34273, in the U.S.
Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=849628&contentType=sentryarticle&channelID=29)